The JAK/STAT Pathway: A Doorway to Understanding Atopic Dermatitis (AD)

Date: Friday 24 September 2021
Time: 13.15 – 14.30  PM CET

Chair: Prof. Sonja Ständer

Program

13.15 – 13.20

Welcome and introduction
Prof. Sonja Ständer

 

13.20- 13.40

The Role of the JAK/STAT Pathway in the Pathophysiology of Atopic Dermatitis 
Dr. Kenji Kabashima

13.40- 14.00

The Development of Small Molecule JAK Inhibitors: An Industry Perspective
Dave Martin – Pfizer JAK Franchise Research Lead

14.00- 14.20

What Role does the JAK/STAT Pathway Play in the Neuroimmune Mechanisms of in AD-related Pruritus?
Prof. Sonja Ständer

14.20- 14.30

Live Q&A